Golden State Medical Supply carbamazepine recalled for black specks
Golden State Medical Supply is recalling Carbamazepine Tablets, USP 200mg due to black specks found in some tablets. This is a manufacturing quality issue. The affected lots were distributed nationwide.
From the FDA notice · Read the official notice ↗ · All Golden State Medical Supply recalls
What to do
- Check if you have one of the affected lot numbers: GS067429, GS068091, GS067430, or GS068090 (all expiring 5/31/2028)
- Contact your pharmacist or doctor if you have this medication
- Do not stop taking your carbamazepine without medical advice; your doctor can help you get unaffected tablets
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 1200 bottles
- Illnesses reported
- None reported
- Manufactured in
- 5187 Camino Ruiz, Camarillo, CA, United States
- Classification
- Class II
- Recall number
- D-0771-2026
In the FDA's words
- Description
- Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA CGMP deviations: tablets with black specks. Lot #: a) GS067429, GS068091, Exp 5/31/2028; b) GS067430, GS068090, Exp 5/31/2028 Distribution: USA Nationwide Affected quantity: 1200 bottles
- Hazard
- CGMP deviations: tablets with black specks.
More from Golden State Medical Supply
See all- Golden State prasugrel tablets recalled for failed dissolution
ModerateFDASep 9, 2026